|
Q1 2021
Filed on May 13, 2021
|
800,000
|
N/A
|
|
|
Q1 2021
Filed on May 13, 2021
|
60,000
|
$26.02 - $26.33
$1.56M - $1.58M
|
|
|
Q1 2021
Filed on May 13, 2021
|
500,000
|
N/A
|
|
|
Q1 2021
Filed on May 13, 2021
|
6,757,053
|
N/A
|
|
|
Q1 2021
Filed on May 13, 2021
|
33
|
$142.98 - $191.37
$4.72K - $6.32K
|
|
|
Q1 2021
Filed on May 13, 2021
|
396,757
|
$24.03 - $28.98
$9.53M - $11.5M
|
|
|
Q1 2021
Filed on May 13, 2021
|
175,000
|
N/A
|
|
|
Q1 2021
Filed on May 13, 2021
|
417,539
|
$10.99 - $23.15
$4.59M - $9.67M
|
|
|
Q1 2021
Filed on May 13, 2021
|
10,000
|
$7.61 - $16.72
$76.1K - $167K
|
|
|
Q1 2021
Filed on May 13, 2021
|
942,000
|
$29.22 - $31.87
$27.5M - $30M
|
|
Eyepoint Pharmaceuticals Inc
|
Q4 2020
Filed on Feb 10, 2021
|
4,137,500
|
N/A
|
|
Flying Eagle Acquisition Cor
|
Q4 2020
Filed on Feb 10, 2021
|
700,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
1,516,750
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
10,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
13,229
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
15,963
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
1,210,766
|
$9.12 - $14.49
$11M - $17.5M
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
33,791
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
1,543,872
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
362,370
|
$30.19 - $45.49
$10.9M - $16.5M
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
275,934
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
1,643,150
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
56,306
|
$28.32 - $31.54
$1.59M - $1.78M
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
125,000
|
$15.38 - $28.87
$1.92M - $3.61M
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
27,298
|
N/A
|
|
Ivy High Income Opportunitie
|
Q4 2020
Filed on Feb 10, 2021
|
10,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
450
|
$25.32 - $31.87
$11.4K - $14.3K
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
20,007
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
1,236,935
|
$3.2 - $4.98
$3.96M - $6.16M
|
|
Constellation Pharmceticls I
|
Q4 2020
Filed on Feb 10, 2021
|
1,080,251
|
N/A
|
|
Advanced Disp Svcs Inc Del
|
Q4 2020
Filed on Feb 10, 2021
|
1,164,742
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
8,440
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
5,597
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
16,158
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
866,529
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
1,769,944
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
67,100
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
2,774
|
$73.87 - $77.5
$205K - $215K
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
1,118,110
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
3,089,151
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
5,691
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
30,000,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
1,472
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
14,133
|
$5.65 - $8.06
$79.9K - $114K
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
409,080
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
141,252
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
52,508
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
54,458
|
N/A
|
|
|
Q4 2020
Filed on Feb 10, 2021
|
406,284
|
$61.72 - $102.33
$25.1M - $41.6M
|
|
Biomarin Pharmaceutical Inc
|
Q4 2020
Filed on Feb 10, 2021
|
29,700,000
|
N/A
|
|